Palo Alto – December 10, 2025 – WCP is delighted to release the MedTech Market Update, Q3 2025, authored by senior bankers Juliesta Sylvester PhD and Michael Magnani, and by analyst Ted Celentino.
The report covers the following key points and more:
- MedTech enters its next expansion phase as innovation-led categories — robotics, structural heart, PFA, and diabetes devices — outpace broader healthcare growth
- How strategic acquirers are recalibrating deal theses amid falling trading multiples, persistent macro headwinds, and rising demand for supply-chain resilience
- Where the most attractive acquisition targets are emerging as high-growth niches mature and category leaders consolidate share across devices and diagnostics
- Which buyers — strategics vs. private equity — are shaping MedTech M&A as EV/Revenue multiples expand from 2- 3x in 2022 to 5- 6x in 2025
- Why investors are increasingly bundling AI-enabled diagnostics, cybersecurity, and surgical technologies to build differentiated portfolios with operating synergies
- Funding behaviors signal a market prioritizing disciplined capital deployment as venture investment softens and median deal sizes stabilize at modest levels
- Valuations track upward with company maturity as deal metrics show widening dispersion across revenue multiples, investment size, and buyer types
- A curated view of promising MedTech segments and targets positioned to benefit from sustained innovation cycles, regulatory clarity, and global data-integration tailwinds
Get the report here:
Woodside Capital Partners is a leading corporate finance advisory firm for tech companies in M&A and financings in the $30M –$500M enterprise value segment. The firm has worked with extraordinary entrepreneurs and investors since 2001, providing ultra-personalized service to its clients. Our team has global vision and reach, and has completed hundreds of successful engagements. We have deep industry knowledge and extensive domain and transaction experience in these and other sectors: Artificial Intelligence, CyberSecurity, HR Tech, Digital Advertising and Marketing, Autonomous Vehicles, ADAS, Computer Vision, Aerospace and Defense, CloudTech, Enterprise Software, IT Services, Information Security, FinTech, Internet of Things, Networking / Infrastructure, Robotics, Semiconductors, Quantum, Energy Storage, Digital Health & Virtual Care, Diagnostic, Medical Devices & Precision Medicine, Healthcare IT & Data Analytics Platforms, AI & Automation in Clinical Decision Support, Revenue Cycle Management & Financial Ops, Behavioral & Mental Health Tech, Value-Based Care & Preventive/Wellness Platforms, Healthcare Infrastructure & Cybersecurity. Woodside Capital Partners is a specialist in cross-border transactions, and has extensive relationships among venture capitalists, private equity investors, and corporate executives from Global 1000 companies.
Questions? Please contact Juliesta Sylvester PhD, Managing Director, Woodside Capital Partners at jsylvester@woodsidecap.com.